Verastem Oncology prices USD 250 million common stock, pre — funded warrant offering
Verastem priced an underwritten follow-on offering of 30,937,500 common shares at USD 8.00 per share. Deal includes pre-funded warrants for 312,503 shares at USD 7.9999 each, with a USD 0.0001 exercise price. Gross proceeds expected to total about USD 250 million, before fees. Closing targeted for about Oct. 15, 2026,